CY1121241T1 - Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων - Google Patents

Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Info

Publication number
CY1121241T1
CY1121241T1 CY20181100951T CY181100951T CY1121241T1 CY 1121241 T1 CY1121241 T1 CY 1121241T1 CY 20181100951 T CY20181100951 T CY 20181100951T CY 181100951 T CY181100951 T CY 181100951T CY 1121241 T1 CY1121241 T1 CY 1121241T1
Authority
CY
Cyprus
Prior art keywords
solvent
particles
mixing method
pharmaceutical ingredients
coated
Prior art date
Application number
CY20181100951T
Other languages
Greek (el)
English (en)
Inventor
Rajesh N. Dave
Daniel TO
Maxx CAPECE
Original Assignee
New Jersey Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Institute Of Technology filed Critical New Jersey Institute Of Technology
Publication of CY1121241T1 publication Critical patent/CY1121241T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5063Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20181100951T 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων CY1121241T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/651,977 US9107851B2 (en) 2012-10-15 2012-10-15 Solventless mixing process for coating pharmaceutical ingredients
PCT/US2013/064058 WO2014062444A1 (en) 2012-10-15 2013-10-09 Solventless mixing process for coating pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
CY1121241T1 true CY1121241T1 (el) 2020-05-29

Family

ID=49474713

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100951T CY1121241T1 (el) 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Country Status (16)

Country Link
US (1) US9107851B2 (pt)
EP (1) EP2906205B1 (pt)
JP (1) JP6159504B2 (pt)
CN (1) CN104853751B (pt)
AR (1) AR093013A1 (pt)
BR (1) BR112015008285B1 (pt)
CY (1) CY1121241T1 (pt)
DK (1) DK2906205T3 (pt)
ES (1) ES2688889T3 (pt)
HR (1) HRP20181463T1 (pt)
HU (1) HUE039772T2 (pt)
PL (1) PL2906205T3 (pt)
PT (1) PT2906205T (pt)
RS (1) RS57918B1 (pt)
SI (1) SI2906205T1 (pt)
WO (1) WO2014062444A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016011412A1 (en) 2014-07-17 2016-01-21 Ada Technologies, Inc. Extreme long life, high energy density batteries and method of making and using the same
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
WO2016209460A2 (en) 2015-05-21 2016-12-29 Ada Technologies, Inc. High energy density hybrid pseudocapacitors and method of making and using the same
US12027661B2 (en) 2015-06-01 2024-07-02 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US11996564B2 (en) 2015-06-01 2024-05-28 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US10692659B2 (en) 2015-07-31 2020-06-23 Ada Technologies, Inc. High energy and power electrochemical device and method of making and using same
JP7069538B2 (ja) * 2016-12-05 2022-05-18 マルボシ酢株式会社 食酢含有飲料組成物
US11024846B2 (en) 2017-03-23 2021-06-01 Ada Technologies, Inc. High energy/power density, long cycle life, safe lithium-ion battery capable of long-term deep discharge/storage near zero volt and method of making and using the same
JPWO2019009335A1 (ja) * 2017-07-04 2020-07-02 村上 正裕 微粒子の製造方法及び微粒子
SG11202108690YA (en) 2019-02-22 2021-09-29 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
TW202045142A (zh) * 2019-02-22 2020-12-16 英商康泰倫特英國斯文敦載迪斯有限公司 將儲存期間藥物顆粒塗覆材料的黏聚最小化以穩定化醫藥產品的崩解時間
EP3927313A1 (en) 2019-02-22 2021-12-29 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
US20210009767A1 (en) * 2019-07-11 2021-01-14 International Flavors & Fragrances Inc. Solventless particle coating via acoustic mixing
IL300129A (en) 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Pharmaceutical preparations containing a coated API

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628945A (en) 1992-08-03 1997-05-13 Riman; Richard E. Multicomponent powder mixing process and compositions produced thereby
DE69328172T2 (de) * 1992-12-25 2000-12-21 Tdk Corp Lithium-sekundärbatterie
US5769917A (en) * 1996-12-09 1998-06-23 Belko; William C. Process for producing low shrink ceramic bodies
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DE10062176A1 (de) * 2000-12-14 2002-07-04 Wacker Polymer Systems Gmbh Polyvinylacetal-gepfropfte Polymerisate
US8163114B2 (en) 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
DE102004059792A1 (de) * 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US20060210694A1 (en) * 2005-03-18 2006-09-21 Chappell Rulon A Anti-caking agents and methods
US7862848B2 (en) 2005-08-03 2011-01-04 The University Of Western Ontario Direct coating solid dosage forms using powdered materials
KR101445957B1 (ko) * 2010-06-08 2014-09-29 각코우호우징 고베가쿠인 코팅 입자 및 코팅 입자의 제조 방법
GB201205632D0 (en) 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them

Also Published As

Publication number Publication date
HRP20181463T1 (hr) 2018-12-14
SI2906205T1 (sl) 2018-12-31
ES2688889T3 (es) 2018-11-07
PT2906205T (pt) 2018-11-07
PL2906205T3 (pl) 2019-03-29
AR093013A1 (es) 2015-05-13
DK2906205T3 (en) 2018-09-24
RS57918B1 (sr) 2019-01-31
EP2906205B1 (en) 2018-06-13
CN104853751A (zh) 2015-08-19
WO2014062444A1 (en) 2014-04-24
BR112015008285B1 (pt) 2022-11-16
BR112015008285A2 (pt) 2017-07-04
EP2906205A1 (en) 2015-08-19
HUE039772T2 (hu) 2019-02-28
US9107851B2 (en) 2015-08-18
US20140106059A1 (en) 2014-04-17
JP2015533162A (ja) 2015-11-19
CN104853751B (zh) 2018-06-22
JP6159504B2 (ja) 2017-07-05

Similar Documents

Publication Publication Date Title
CY1121241T1 (el) Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
EP3463665A4 (en) COVALENTLY MODIFIED SURFACES, KITS AND METHODS OF PRODUCTION AND USE
EP4285928A3 (en) Anti-pdl1 antibody formulations
EP3679924A3 (en) Formulation comprising particles
MX2015012933A (es) Micrordenamiento para suministro de agente terapeutico y metodos de uso.
EP3362451A4 (en) INHIBITORS OF INFLUENZAVIRUS REPLICATION, METHOD OF USE AND USES THEREOF
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
EP3500307A4 (en) USE OF A VCP INHIBITOR AND ONCOLYTIC VIRUS IN THE PREPARATION OF AN ACTIVE AGGREGATE AGAINST CANCER
HK1245776A1 (zh) 流感病毒複製抑制劑及其使用方法和用途
BR112018010743A2 (pt) ?método para fabricação de um pó farmacêutico formulado, e, pó farmacêutico formulado?
AU2018348359A8 (en) Extended release pharmaceutical formulation and methods of treatment
EP3423040A4 (en) MICRO NEEDLE PARTICLES, COMPOSITIONS AND METHODS FOR TREATING AND ADMINISTERING A SUBSTANCE OF INTEREST
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
WO2014153495A3 (en) Novel stat3 inhibitors
PL3380526T3 (pl) Przyjazny dla środowiska sposób przygotowywania nanocelulozy i jej pochodnych
EP3277806A4 (en) Methods of forming nanostructures using self-assembled nucleic acids, and nanostructures thereof
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
GB2528421A (en) Methods and processes for application of drug delivery polymeric coatings
EP3313374A4 (en) ACTIVE SUBSTANCES CAPTAINED IN AMPHIPHILIC POLYMERS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
EP3558384A4 (en) BIOCOMPATIBLES AND HYDROPHILIC POLYMER CONJUGATE FOR THE TARGETED RELEASE OF AN ACTIVE SUBSTANCE
WO2017120098A8 (en) Stimuli-responsive polymeric nanoparticles, methods of making stimuli-responsive polymeric nanoparticles, and methods of using stimuli-responsive polymeric nanoparticles
CY1121708T1 (el) Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση
BR112017012400A8 (pt) Complexo fármaco-resina, partícula de liberação estendida, formulação farmacêutica, método para formar um complexo de fármaco-resina revestido e processo para a preparação de um complexo fármaco-resina
SA118400097B1 (ar) تخليق جسيمات حمض الإيفلايونيك متناهي الصغر